Economic burden of obesity and its complications in Germany
Economic burden of obesity and its complications in Germany
复制标题
德国肥胖及其并发症的经济负担
DOI：
--
复制
发表时间：
2003
期刊：
影响因子：
--
通讯作者：
R. Bergemann
中科院分区：
文献类型：
--
作者：
B. Sander;R. Bergemann
这项研究估计了肥胖疾病的经济负担和选定的合并症的健康结果和成本的社会和医疗保健支付者在德国。根据文献数据，使用比值比/相对风险和患病率估计仅归因于肥胖的选定疾病（合并症）的比例。采用自上而下的方法将医疗保健支出与肥胖患者（BMI 30+）和主要合并症的数量相匹配，以评估总体直接和间接成本。在德国，大约有1224万肥胖成年人，其中206 - 376万人患有选定的合并症。从社会角度来看，肥胖和合并症的总成本为每年27.01 - 56.82亿欧元，仅直接治疗成本就占13.43 - 26.99亿欧元，给医疗保健系统带来了重大负担。鉴于疾病造成的经济负担的严重性，有必要在卫生政策一级开展进一步的研究和行动。
This study estimated the economic burden of illness of obesity and selected comorbidities in terms of health outcome and costs to society and healthcare payer in Germany. The proportions of selected diseases (comorbidities) attributable solely to obesity were estimated using odds ratios/relative risks and prevalences based on data from the literature. The top-down approach was employed to match healthcare spending with the number of patients suffering from obesity (BMI 30+) and the major comorbidities to evaluate overall direct and indirect costs. In Germany there are approximately 12.24 million obese adults, 2.06–3.76 million of whom suffer from the selected comorbidities. From a societal perspective the total costs for obesity and comorbidities are €2,701–5,682 million per year and the direct treatment costs alone account for €1,343–2,699 million, imposing a major burden to the healthcare system. In view of the magnitude of the economic burden of illness there is a need for both further research and action at the health policy level.
DOI：
10.1001/jama.1995.03520300035033
发表时间：
1995-02
期刊：
JAMA
影响因子：
--
作者：
W. Willett;J. Manson;M. Stampfer;G. Colditz;B. Rosner;F. Speizer;C. Hennekens
通讯作者：
W. Willett;J. Manson;M. Stampfer;G. Colditz;B. Rosner;F. Speizer;C. Hennekens
影响因子：
158.5
作者：
MANSON, JAE;COLDITZ, GA;HENNEKENS, CH
通讯作者：
HENNEKENS, CH